ID22536A - Garam amina kristal dari cefdinir - Google Patents

Garam amina kristal dari cefdinir

Info

Publication number
ID22536A
ID22536A IDW991137A ID991137A ID22536A ID 22536 A ID22536 A ID 22536A ID W991137 A IDW991137 A ID W991137A ID 991137 A ID991137 A ID 991137A ID 22536 A ID22536 A ID 22536A
Authority
ID
Indonesia
Prior art keywords
cefdinir
salt
amina
crystal
dicyclohexylamine
Prior art date
Application number
IDW991137A
Other languages
English (en)
Indonesian (id)
Inventor
Hubert Sturm
Siegfried Wolf
Johannes Ludescher
Original Assignee
Biochemie Gessellschaft M B H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochemie Gessellschaft M B H filed Critical Biochemie Gessellschaft M B H
Publication of ID22536A publication Critical patent/ID22536A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/227-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDW991137A 1997-04-04 1998-04-02 Garam amina kristal dari cefdinir ID22536A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0057097A AT405283B (de) 1997-04-04 1997-04-04 Neues kristallines 7-(z)-(2-(2-aminothiazol-4-yl) -2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4- carbonsäure dicyclohexylammoniumsalz und verfahren zu dessen herstellung

Publications (1)

Publication Number Publication Date
ID22536A true ID22536A (id) 1999-11-04

Family

ID=3494111

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991137A ID22536A (id) 1997-04-04 1998-04-02 Garam amina kristal dari cefdinir

Country Status (18)

Country Link
US (1) US6350869B1 (de)
EP (1) EP0973779B1 (de)
JP (1) JP3421354B2 (de)
KR (1) KR100442717B1 (de)
CN (1) CN1139596C (de)
AT (2) AT405283B (de)
AU (1) AU731413B2 (de)
BR (1) BR9809745A (de)
CA (1) CA2283718A1 (de)
DE (1) DE69816056T2 (de)
HU (1) HUP0002987A3 (de)
ID (1) ID22536A (de)
IL (1) IL131755A0 (de)
NO (1) NO994466D0 (de)
PL (1) PL335620A1 (de)
SK (1) SK134399A3 (de)
TR (1) TR199902406T2 (de)
WO (1) WO1998045299A1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080113025A1 (en) * 1998-11-02 2008-05-15 Elan Pharma International Limited Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
KR100451672B1 (ko) * 2001-06-05 2004-10-08 한미약품 주식회사 결정성 세프디니르 산부가염, 이의 제조방법 및 이를이용한 세프디니르의 제조방법
ITMI20020913A0 (it) * 2002-04-29 2002-04-29 Acs Dobfar Spa Nuova forma cristallina del cefdinir
ATE501154T1 (de) 2002-08-13 2011-03-15 Sandoz Ag Ein cefdinir-zwischenprodukt
ITMI20022076A1 (it) 2002-10-01 2004-04-02 Antibioticos Spa Sali di intermedi del cefdinir.
WO2004046154A1 (en) * 2002-11-15 2004-06-03 Orchid Chemicals & Pharmaceuticals Ltd Novel amorphous hydrate of a cephalosporin antibiotic
ITMI20022724A1 (it) * 2002-12-20 2004-06-21 Antibioticos Spa Sali cristallini del cefdinir.
EP1609793A4 (de) * 2003-03-24 2008-06-25 Sandoz Ag Neuer kristall von 7-¬2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido-3-vinyl-3-cephem-4-carbonsäure(syn-isomer) und verfahren zu dessen herstellung
WO2004104010A1 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited Crystalline form of cefdinir
US20040242556A1 (en) * 2003-06-02 2004-12-02 Ramesh Dandala Novel crystalline form of cefdinir
US20050137182A1 (en) * 2003-06-02 2005-06-23 Ramesh Dandala Novel crystalline form of cefdinir
US20050113355A1 (en) * 2003-09-12 2005-05-26 Duerst Richard W. Cefdinir pyridine salt
US20050059819A1 (en) * 2003-09-12 2005-03-17 Duerst Richard W. Cefdinir pyridine salt
US20050059818A1 (en) * 2003-09-12 2005-03-17 Duerst Richard W. Polymorph of a pharmaceutical
US20060142563A1 (en) * 2004-03-16 2006-06-29 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
US20050209211A1 (en) * 2004-03-16 2005-09-22 Devalina Law Trihemihydrate, anhydrate and novel hydrate forms of Cefdinir
US20060211676A1 (en) * 2004-03-16 2006-09-21 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
US20060142261A1 (en) * 2004-03-16 2006-06-29 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
WO2005090360A1 (en) * 2004-03-19 2005-09-29 Orchid Chemicals & Pharmaceuticals Limited Novel polymorph of cefdinir
US20060069079A1 (en) * 2004-09-27 2006-03-30 Sever Nancy E Stable amorphous cefdinir
US20050245738A1 (en) * 2004-05-03 2005-11-03 Lupin Ltd Stable bioavailable crystalline form or cefdinir and a process for the preparation thereof
WO2006010978A1 (en) * 2004-06-30 2006-02-02 Wockhardt Limited Cefdinir polymorphic forms, and imidazole salt
JP4856795B2 (ja) 2004-07-05 2012-01-18 オーキッド ケミカルズ アンド ファーマシューティカルズ リミテッド セファロスポリン抗生物質の製造における新規な塩
WO2006018807A1 (en) * 2004-08-16 2006-02-23 Ranbaxy Laboratories Limited Crystalline forms of cefdinir
ITMI20042231A1 (it) * 2004-11-19 2005-02-19 Antibioticos Spa Cefdinir sale d'ammonio in forma cristallina
WO2006059753A1 (en) * 2004-11-30 2006-06-08 Astellas Pharma Inc. Novel oral pharmaceutical suspension of cefdinir crystal
GB2421024A (en) * 2004-12-07 2006-06-14 Sandoz Ag Cefdinir crystalline form C
WO2006117794A1 (en) * 2005-05-02 2006-11-09 Hetero Drugs Limited A novel crystalline form of cefdinir
US20080287673A1 (en) * 2005-06-15 2008-11-20 Parthasaradhi Reddy Bandk Cefdinir process
CN1903860B (zh) * 2005-07-25 2012-01-18 四川抗菌素工业研究所有限公司 溶媒法制备高纯度头孢他美钠工艺及医药用途
KR100912214B1 (ko) * 2005-10-31 2009-08-14 테바 파마슈티컬 인더스트리즈 리미티드 세프디니르 세슘 염의 결정형
US20070128268A1 (en) * 2005-12-07 2007-06-07 Herwig Jennewein Pharmaceutical compositions comprising an antibiotic
CN101481383B (zh) 2008-12-31 2012-01-11 杭州奥默医药技术有限公司 头孢地尼酸式复盐化合物及制备方法
TR200909784A1 (tr) * 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Yeni sefdinir tuzları
US8614315B2 (en) 2009-12-25 2013-12-24 Mahmut Bilgic Cefdinir and cefixime formulations and uses thereof
CN102010427B (zh) * 2010-11-19 2012-09-12 苏州中联化学制药有限公司 一种头孢地尼的制备方法
CN101974020B (zh) * 2010-11-19 2012-09-12 苏州中联化学制药有限公司 一种头孢地尼的合成方法
CN103012433B (zh) * 2012-12-13 2015-06-24 珠海保税区丽珠合成制药有限公司 头孢地尼晶型b的制备方法
CN108546270B (zh) * 2017-05-31 2019-11-08 郑州大学第一附属医院 制备头孢地尼的方法
CN107286148B (zh) * 2017-06-20 2019-10-15 广州市桐晖通医药科技有限公司 一种头孢地尼的制备方法及其新的中间体化合物
CN111635419B (zh) * 2020-07-13 2022-05-24 广药白云山化学制药(珠海)有限公司 一种头孢地尼精制母液的处理方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5564M (de) 1964-03-14 1968-01-02
GB8323034D0 (en) 1983-08-26 1983-09-28 Fujisawo Pharmaceutical Co Ltd 7-substituted-3-vinyl-3-cephem compounds
ZA885709B (en) * 1987-08-19 1989-04-26 Fujisawa Pharmaceutical Co Novel crystalline 7-(2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid(syn isomer)
EP0630380B1 (de) * 1992-02-05 2001-09-05 Biochemie Gesellschaft M.B.H. Verfahren zur reinigung eines 3-cephem-4-carboxyl säure derivates
CN1130908A (zh) * 1994-07-22 1996-09-11 安蒂比奥蒂科斯公司 戊二酸单酰基7-氨基头孢烷酸衍生物及其制备方法
AT403049B (de) 1995-08-14 1997-10-27 Biochemie Gmbh Abreicherung von 7-adca in 3-vinyl-aca
ATE218572T1 (de) 1995-12-27 2002-06-15 Hanmi Pharmaceutical Co Ltd Verfahren zur herstellung von cefdinir
AT404251B (de) * 1996-08-14 1998-10-27 Biochemie Gmbh Neues kristallines salz von cefixim

Also Published As

Publication number Publication date
IL131755A0 (en) 2001-03-19
CN1251590A (zh) 2000-04-26
NO994466L (no) 1999-09-15
AT405283B (de) 1999-06-25
KR20010005907A (ko) 2001-01-15
BR9809745A (pt) 2000-06-20
WO1998045299A1 (en) 1998-10-15
HUP0002987A2 (hu) 2001-02-28
EP0973779A1 (de) 2000-01-26
DE69816056T2 (de) 2004-04-15
CA2283718A1 (en) 1998-10-15
DE69816056D1 (de) 2003-08-07
ATA57097A (de) 1998-11-15
PL335620A1 (en) 2000-05-08
NO994466D0 (no) 1999-09-15
JP3421354B2 (ja) 2003-06-30
KR100442717B1 (ko) 2004-08-02
ATE244249T1 (de) 2003-07-15
TR199902406T2 (xx) 2000-02-21
CN1139596C (zh) 2004-02-25
SK134399A3 (en) 2000-05-16
HUP0002987A3 (en) 2001-04-28
US6350869B1 (en) 2002-02-26
JP2000514833A (ja) 2000-11-07
AU7428898A (en) 1998-10-30
AU731413B2 (en) 2001-03-29
EP0973779B1 (de) 2003-07-02

Similar Documents

Publication Publication Date Title
ID22536A (id) Garam amina kristal dari cefdinir
TR199902587T2 (xx) Fumarik asid t�revlerinin kullan�lmas�.
AU8581991A (en) Mercaptoacetylamide derivatives as inhibitors of enkephalinase and ACE, and processes for their production
DE59606920D1 (de) Chirale methylphenyloxazolidinone
DK0941094T3 (da) Fremgangsmåde til fremstilling af ophthalmiske suspensioner indeholdende brinzolamid
ID23374A (id) Halogenopirimidin
MY136446A (en) New salts of valsartan
DE50012408D1 (de) Polyurethanlösungen mit alkoxysilanstruktureinheiten
MXPA03010201A (es) Derivados de 2-piridin-ciclohexan-1,4-diamina sustituidos.
DK0691155T3 (da) Fremgangsmåde til afsyring af en gas til fremstilling af koncentrerede, sure gasser
DE69202307D1 (de) Kryogenisches Rektifikationsverfahren zur Herstellung von gereinigtem Argon.
IN2012DE00109A (de)
MX9705726A (es) Amidas del acido alcoximinoacetico.
DE3680429D1 (de) Gasfoerderungsverfahren, angewandt fuer einen veraenderlichen bedarf.
DE69807930D1 (de) Produktion von hochdruckgas
DE59911666D1 (de) Kristallmodifikation b von 8-cyan- 1-cyclopropyl -7-(1s,6s-2, 8-diazabicyclo - 4.3.0]nonan -8-yl)-6- fluor-1, 4-dihydro- 4-oxo-3- chinolincarbonsaure
DE69814806D1 (de) Hochdruckverfahren zur Rückgewinnung von Schwefel
BR0012622A (pt) Derivados de 3-amino-2-benzil-1-fenil-propano
FR2686898B1 (fr) Methode de production de la l-phenylalanine.
FI940265L (fi) Jatkuvatoiminen menetelmä dimetoksietanaalin teolliseksi valmistamiseksi
ATE242763T1 (de) Methoximinophenylessigsäureamide
SE9602416D0 (sv) New forms of an organic salt of N'N-diacetylcystine
ID28020A (id) Senyawa-senyawa sulfonilsianamida tersubstitusi, prose-proses pembuatannya dan penggunaannya sebagai obat
IL127930A0 (en) Verapamil as a medicament for the treatment of angina
EP0601353A3 (en) Process for the production of n-(2-sulphatoethyl) piperazine with a high purity.